TrialThe British journal of ophthalmology2022

Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK.

Yuichiro Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.